VOYAGER THERAPEUTICS INC's ticker is and the CUSIP is 92915B956. A total of 3 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $159 | +50.0% | 20,600 | +121.5% | 0.00% | – |
| Q2 2023 | $106 | -58.6% | 9,300 | -72.1% | 0.00% | – |
| Q1 2023 | $256 | +884.6% | 33,300 | +656.8% | 0.00% | – |
| Q4 2022 | $26 | -99.9% | 4,400 | +12.8% | 0.00% | – |
| Q3 2022 | $23,000 | +15.0% | 3,900 | +14.7% | 0.00% | – |
| Q2 2022 | $20,000 | -76.7% | 3,400 | -69.9% | 0.00% | – |
| Q1 2022 | $86,000 | +437.5% | 11,300 | +85.2% | 0.00% | – |
| Q4 2021 | $16,000 | +166.7% | 6,100 | +258.8% | 0.00% | – |
| Q3 2021 | $6,000 | -14.3% | 1,700 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | -75.0% | 1,700 | +2733.3% | 0.00% | – |
| Q1 2021 | $28,000 | +133.3% | 60 | +500.0% | 0.00% | – |
| Q2 2020 | $12,000 | +33.3% | 10 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | -30.8% | 10 | 0.0% | 0.00% | – |
| Q4 2019 | $13,000 | -27.8% | 10 | -9.1% | 0.00% | – |
| Q3 2019 | $18,000 | +1700.0% | 11 | +1000.0% | 0.00% | – |
| Q1 2019 | $1,000 | -88.9% | 1 | -80.0% | 0.00% | – |
| Q3 2018 | $9,000 | -52.6% | 5 | -50.0% | 0.00% | – |
| Q2 2018 | $19,000 | +850.0% | 10 | -81.8% | 0.00% | – |
| Q1 2018 | $2,000 | -96.9% | 55 | -62.8% | 0.00% | -100.0% |
| Q4 2017 | $64,000 | – | 148 | +1133.3% | 0.00% | – |
| Q3 2017 | $0 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,600 | $9,000 | 0.00% |
| SIMPLEX TRADING, LLC | 3,900 | $23,000 | 0.00% |
| JANE STREET GROUP, LLC | 12,500 | $74,000 | 0.00% |